Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$9.12 - $14.49 $253,937 - $403,459
-27,844 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$10.46 - $14.46 $7,478 - $10,338
-715 Reduced 2.5%
27,844 $328,000
Q2 2020

Aug 14, 2020

BUY
$12.0 - $16.13 $342,708 - $460,656
28,559 New
28,559 $422,000
Q4 2017

Feb 14, 2018

SELL
$50.85 - $65.1 $283,387 - $362,802
-5,573 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$48.6 - $60.1 $270,847 - $334,937
5,573
5,573 $271,000

Others Institutions Holding AERI

About AERIE PHARMACEUTICALS INC


  • Ticker AERI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,390,500
  • Description
  • Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...
More about AERI
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.